Glow Blend Research
Product image coming soon
Glow Blend: BPC-157 + GHK-Cu + TB-500 Research Combination
Glow Blend is a pre-mixed research combination vial containing BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) — 70mg total per vial. It is supplied as a combined lyophilised powder for laboratory research examining the combined signalling profiles of these three peptides in a single preparation. Each component is verified individually by HPLC to greater than or equal to 98% purity before combination.
Composition per Vial
| Component | Amount | CAS Number | Primary Research Target |
|---|---|---|---|
| BPC-157 | 10mg | 137525-51-0 | NO signalling, angiogenesis, growth factor expression |
| GHK-Cu | 50mg | 49557-75-7 | Copper transport, MMP regulation, wound healing |
| TB-500 | 10mg | 77591-33-4 | Actin dynamics, G-actin sequestration, cell migration |
| Total | 70mg | — | Combined peptide signalling research |
Glow Blend: Three-Peptide Signalling Profile
Analytical Data
| Property | Value |
|---|---|
| Individual component purity | greater than or equal to 98% each, as verified by HPLC |
| Form | Combined lyophilised powder |
| Storage | -20 degrees C, protected from light and moisture |
| Reconstitution | Bacteriostatic water recommended |
Research Rationale: Complementary Signalling Pathways
The three components of Glow Blend target distinct but complementary cellular signalling pathways, making them relevant for research examining combined or synergistic peptide signalling in tissue biology models.
BPC-157 component. As detailed in the BPC-157 research overview, BPC-157 has been studied in the context of nitric oxide signalling, VEGF expression, FAK-paxillin pathway modulation, and actin cytoskeletal organisation. Its pro-angiogenic and tissue-signalling properties make it one of the most studied research peptides in regenerative biology models.
GHK-Cu component. The GHK-Cu tripeptide (detailed in the GHK-Cu research overview) has been studied for its role in copper transport, collagen synthesis regulation, matrix metalloproteinase (MMP) balance, and gene expression changes in fibroblast models. The copper chelation chemistry of GHK provides a distinct mechanistic angle from the other two peptides.
TB-500 component. TB-500 (detailed in the TB-500 research overview) acts through the LKKTET actin-binding motif to sequester G-actin and modulate the G/F-actin ratio in cells. This influences cell migration, lamellipodia formation, and cytoskeletal dynamics — processes studied in wound closure, angiogenesis, and tissue repair models.
Research Context
The combination of these three peptides in a single research preparation allows investigators to study combined signalling without the need for separate reconstitution and mixing of individual components. Researchers studying wound healing, tissue biology, or matrix remodelling may find the combined preparation convenient for initial screening studies before moving to individual components for mechanistic dissection.
For mechanistic studies on individual components, Signal Labs supplies each peptide separately: BPC-157, GHK-Cu, and TB-500.
Individual Component Signalling Profile
| Component | Dose per vial | Primary mechanism | Key research pathway |
|---|---|---|---|
| BPC-157 | 10mg | NO signalling, FAK-paxillin, VEGF | Angiogenesis, mucosal, neurochemistry |
| GHK-Cu | 50mg | Cu2+ coordination, MMP regulation, SP1 | Matrix remodelling, gene expression |
| TB-500 | 10mg | G-actin sequestration (LKKTET) | Cell migration, cytoskeletal dynamics |
Research Design Considerations for Combination Preparations
When using Glow Blend in laboratory research, several design considerations apply:
Concentration ratios. The 10:50:10 mg ratio of BPC-157:GHK-Cu:TB-500 means GHK-Cu is present at 5x the molar quantity of BPC-157 and TB-500 (adjusting for molecular weight differences). Researchers should account for this ratio when designing dose-response experiments and when comparing results to individual compound studies.
Mechanistic attribution. Any observed effects with Glow Blend cannot be attributed to a single component without parallel single-compound control experiments. Signal Labs supplies all three components individually for researchers requiring mechanistic dissection: BPC-157, GHK-Cu, and TB-500.
Synergy vs additivity. Combined peptide preparations raise questions about synergistic, additive, or antagonistic interactions between components. Research examining Glow Blend alongside individual components and two-compound combinations (BPC-157 + TB-500, BPC-157 + GHK-Cu, GHK-Cu + TB-500) would allow systematic characterisation of component interactions.
Copper considerations. The GHK-Cu component introduces copper(II) into the reconstituted solution. Researchers should account for potential copper chelation interactions with media components and should note that copper itself can influence redox chemistry and ROS measurements in cell culture experiments.
Frequently Asked Questions
Why is GHK-Cu present at 50mg compared to 10mg each for BPC-157 and TB-500?
The composition of Glow Blend reflects a formulation choice based on GHK-Cu's molecular weight and research dose ranges relative to the other two components. GHK-Cu is a much smaller molecule (MW ~403 for the copper complex) than BPC-157 (MW ~1420) or TB-500 (MW ~4963). The 50mg GHK-Cu provides a comparable molar quantity relative to the 10mg doses of the larger peptides, ensuring each component is present in research-relevant amounts.
Can Glow Blend components interact with each other in solution?
All three components are water-soluble and should dissolve independently in bacteriostatic water. The main interaction concern is GHK-Cu's copper(II) content — copper can oxidise free cysteine and methionine residues in other peptides. BPC-157 does not contain cysteine, but does contain methionine... actually BPC-157's sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) contains no methionine either. TB-500 does contain methionine at several positions, and researchers working with the combination over extended periods should be aware of potential copper-mediated oxidation of Met residues in TB-500.
Published Research References
1. Sikiric P, et al. "Brain-gut Axis and Pentadecapeptide BPC 157." *Current Neuropharmacology*, 2016. PMID: 26733888
2. Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide." *International Journal of Molecular Sciences*, 2018. PMID: 29937520
3. Smart N, et al. "Thymosin b4 induces adult epicardial progenitor mobilization and neovascularization." *Nature*, 2007. PMID: 17611540
For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied. Components are not for administration to humans or animals.